Showing 1 to 1 of 1 results
bbc.com
🌐 90% Global Worthiness


Olaparib Improves Survival Rates for Inherited Breast Cancer
A UK trial found that giving olaparib before surgery to women with early-stage BRCA1 or BRCA2 mutated breast cancer led to 100% survival at 36 months in the treatment group, compared to a 89% survival rate in the control group, potentially benefiting over 1,200 UK women annually.
Olaparib Improves Survival Rates for Inherited Breast Cancer
A UK trial found that giving olaparib before surgery to women with early-stage BRCA1 or BRCA2 mutated breast cancer led to 100% survival at 36 months in the treatment group, compared to a 89% survival rate in the control group, potentially benefiting over 1,200 UK women annually.
Progress
48% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results